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A substantial amount of literature has appeared in the last decade on
immunological tolerance (reviewed in 1) . The establishment of thymus-derived
(T) and bone marrow-derived (B) cell cooperative interactions in humoral
immune responses has necessitated reassessment of conceptual and experimental
approaches to the study of tolerance (reviewed in 2) . One of the major issues has
been to define the site of tolerance induction in a given experimental situation .
There is now clear evidence for specific unresponsiveness in both the B- and
T-cell lineages, and critical kinetic and dose threshold differences have been
elucidated by Chiller et al . (3, reviewed in 4) for tolerance induction in T andB
lymphocytes, insofar as thymus-dependent antigens are concerned .
The specific unresponsiveness in the B-cell lineage could be easily induced by injection
of a haptenic determinant coupled to a thymus-independent carrier (5-7) or to
nonimmunogenic synthetic polypeptides (8-12), and this provided us with a very
intriguing experimental system for elucidation of the mechanism of tolerance induction in
the B-cell line . In the case of induction of B-cell tolerance by a DNP derivative of a
copolymer of D-glutamic acid and D-lysine (D-GL),' the maintenance of tolerance of
DNP-specificB cells by serial adoptive transfer (9), and the failure to reverse the tolerance
by enzymatic treatment with trypsin of the tolerant cells (12), imply that tolerance in this
situation reflects deletion of a specific clone of antigen-reactive B cells .
On the other hand, there is also a considerable body of evidence which demonstrates
that unresponsiveness could be induced exclusively at the level of the T cells (3, 13-16) .
This form of tolerance, in contrast to B-cell tolerance, is occasionally associated with
normal or even an increased number of antigen-binding cells . Furthermore, it is
occasionally infectious in certain situations ; thus, T cells from tolerant donors have the
ability to inhibit the immune response of nontolerant cells (17-20) . The implication of
*This investigation was supported by Grant-in-Aids from the Ministry of Education of Japan .
' Abbreviations used in this paper: BSA, bovine serum albumin ; BaA, bacterial a-amylase ; CFA,
complete Freund's adjuvant ; D-GL, copolymer of D-glutamic acid and D-lysine ; GPA, guinea pig
albumin ; HGG, human gamma globulin ; KLH, keyhole limpet hemocyanin ; MGG, mouse gamma
globulin ; NMS, normal mouse serum ; OVA, ovalbumin ; PAB, p-azobenzoate; PFC, plaque-forming
cells .
1308
￿
THE JOURNAL OF EXPERIMENTAL MEDICINE ' VOLUME 141, 1975T . HAMAOKA, U. YAMASHITA, T. TAKAMI, AND M . KITAGAWA
￿
1309
these findings is that tolerance of this type is due, not to deletion or elimination of
antigen-reactive cells, but to an active suppressor T-cell effect in the tolerant cell
population (18-20) . However, in another type of T-cell tolerance model, such as
unresponsiveness to tissue-associated antigens, the lymphoid cells obtained from unre-
sponsive animals exhibit a responsiveness to that antigen when transferred into another
milieu in vivo or in vitro, and this unresponsiveness was easily reproduced by the
administration of serum factor from unresponsive animals (21-24) . Thus, on this occasion,
the unresponsiveness on the T-cell level seems to be induced by a blocking factor in serum
which may inhibit the reaction of T cells with the corresponding antigen (21-24) .
However, another widely accepted explanation for tolerance is that tolerance reflects
deletion of a specific clone of antigen-reactive T cells (25-27) . In this case, the tolerance is
neither infectious nor inducible by the administration of serum from tolerant animals, and
is stable on adoptive transfer. Thus, in contrast to tolerance induction in B lymphocytes,
the mechanism of induction of unresponsiveness to T cells is still a point of debate (28) . A
great deal of this confusion stems from the apparentlycontradictory observation described
above; this is a crucial issue since on it rests the correct interpretation of the fate of
tolerant T cells. For this and related reasons, the establishment of a model in which
unresponsiveness is restricted to the T-cell population may be crucial for elucidation of
some of these problems .
The present studies were undertaken to establish a condition of specific
unresponsiveness of p-azobenzoate (PAB)-reactive helper T lymphocytes in mice
by administration of a PAB derivative of a copolymer of D-GL. A unique feature of
this model was the relative ease with which specific unresponsiveness of
PAB-reactive helper T lymphocytes could be induced in an animal previously
primed to PAR It was of particular interest to obtain PAB-specific unresponsive-
ness on the helper T-cell level in an adoptive transfer system in mice, since such a
model would offer considerable advantage in further experimentation designed to
approach questions concerning the mechanism of cellular events responsible for
tolerance induction on the T-cell level . Utilizing this system, we have found that
the unresponsive state induced in helper T lymphocytes was not broken by serial
adoptive cell transfer, and such tolerance was not mediated by suppressor cells.
Moreover, the tolerance induced in the T cells does not reflect simple coverage of
tolerogen on T-cell receptors in this PAB-D-GL model. Evidence gathered from
the experiment utilizing trypsin treatment of tolerant helper T cells provides a
forceful argument for the concept of central tolerance in T lymphocytes as a
reflection of sub- or intracellular inhibitory events .
Materials and Methods
Proteins and Chemical Reagents .
￿
The copolymer of D-GL was obtained from Pilot Chemicals,
Inc., Watertown, Mass. The polymerhad an average mol wt of 27,000 and a ratio of glutamic acid to
lysine residues of 60:40. Crystalline bacterial a-amylase (BaA) derived from Bacillus subtilis was
purchased from Nagase Sangyo Co . Ltd., Osaka, Japan, and keyholelimpet hemocyanin (KLH) was
obtained from Calbiochem, San Diego, Calif. Mouse gamma globulin (MGG) was prepared from
Ehrlich tumor ascitic fluid by precipitation with !-:a saturated ammonium sulfate and was further
purified through the use of DEAE-cellulose column chromatography with 0.01 M sodium phosphate
buffer, pH 8.0. Human gamma globulin (HGG), Cohn fraction 11 was purchased from Nutritional
Biochemicals Corporation, Cleveland, Ohio and was further purified through a DEAE-cellulose
column as above. Bovine serum albumin (BSA) was purchased from Armour Pharmaceutical Co.,
Chicago, Ill., and hen ovalbumin (OVA) was obtained from Wako Pure Chemical Industries, Ltd.,
Osaka, Japan. These proteins are not immunologically cross-reacting.1310 TOLERANCE IN T LYMPHOCYTES. I
Preparation of Hapten-Carrier Conjugates
DINITROPHENYL [DNP] PROTEIN CONJUGATES . The following DNP conjugates were prepared using
sodium 2,4-dinitrobenzene sulphonate : DNP,-BaA, DNP,-KLH, DNP,-MGG, DNP,,-BSA, and
DNP,-OVA . Subscripts refer to the averagenumber ofDNP groups permolecule of the proteins, and
this was calculated from the absorption readings at 360 and 280 nm in alkaline solution . In these
calculations, the mol wt of BaA, KLH, MGG, BSA, andOVAwere taken as 50,000, 100,000, 160,000,
68,000, and 45,000, respectively .
PAB-CARRIER CONJUGATES .
￿
PAB-D-GL was prepared according to a modification of the method of
Tabachnick and Sobotka (29) : the D-GL was dissolved in borate-buffered saline, pH 9.0, at a
concentration of 5 mg/ml, and a 200-fold excess in molar ratio of diazotized p-aminobenzoate was
then added dropwise over a period of 15 min, with constant stirring, to the protein solution
maintained in an ice bath . During the addition the pH was maintained at 9.0 with 1 NNaOH . After
coupling was allowed to proceed at room temperature for 4 h, the reaction mixture was extensively
dialyzed at 4°C with continuous stirring for at least 7 days, with daily changes of the dialysis fluid.
The average number of moles ofPAB permole ofD-GL was calculated from theabsorption reading at
460 nm in alkaline solution . In the calculation, the molar extinction coefficient of PAB-lysine was
tentatively assumed to be 1,650 at 460 nm based on that of bis(p-azobenzenearsonic acid)diazo-c-
aminocaproic acid (29) . 26 molecules ofPABgroups were found to bind covalently with 1 molecule of
D-GL in the conjugate by this calculation .
PAB,-MGG, DNP,-MGG-PAB andPAB,-HGG were prepared in a similarmanner except that a
100-fold excess in molar ratio of diazotized p-aminobenzoate was reactedwithMGG, DNP,-MGG, or
HGG. Subscripts refer to the average number of moles ofPAB per mole of protein, and this was
calculated from the absorption reading at 460 and 500 nm in alkaline solution, assuming PAB had
coupled to histidine and tyrosine residues of those molecules (29) .
Assay System for Measuring the Activity of PAB-Reactive Helper T Lymphocytes.
￿
The ddO
albino mice, supplied by the Central Breeding Laboratory of Experimental Animals of Osaka
University, Osaka, Japan, were primarily immunized by intraperitoneal injections of 100 kg of
PAB-MGG in complete Freund's adjuvant (CFA) . At various times (2-3 mo) thereafter, the
single-cell suspensions in Eagle's minimal essential medium (MEM) were prepared from thespleens
of these primed mice and used as the source of PAB-primed helper T cells . As aDNP-primed B-cell
source, single-cell suspensions of spleens from mice which had been immunized intraperitoneally
with 100 lug ofDNP-BaAorDNP-KLH in CFAwere used andtransferred intravenously to syngeneic,
irradiated (550-600 R) recipients together with PAB-primed helper T cells . In general, antigenic
stimulation was performed in vitroby adding 100 Fag ofDNP-MGG-PAB to those mixtures of primed
cells immediately before the cell transfer . PAB-reactive helper cell activity in the transferred
PAB-MGG-primed cells was measured by the magnitude of anti-DNP antibody responses of the
DNP-primed B cells in recipient spleens 7 days after the stimulation of DNP-MGG-PAB . The
anti-DNP antibody responses were determined by a modification of thehemolytic plaque technique
as described below. The tolerogen (PAB-D-GL) treatment to the PAB-primed helper T cells was
performed by intraperitoneal injection of the PAB-primed donor animals 3 or 4 days before the cell
transfer . Modifications of this general adoptive transfer scheme and tolerogen treatment are
described in appropriate sections in the Results .
Hemolytic Plaque Assay . Plaque-forming cells (PFC) in the spleens of recipients secreting
anti-DNP antibodies were enumerated by a modification of Cunningham's hemolytic plaque
technique described in detail previously (30) . For this assay, sheep erythrocytes (SRBC) were
conjugated with DNP-BSA by using CrCl, . Single spleen cell suspensions from individual recipient
mice were treated with 0.85% NH,Cl, and washed three times with MEM before assay . Direct PFC
were enumerated after incubation ofmonolayers ofindicator red cells, DNP-BSA-coupledSRBC, and
spleen cells usingguinea pigserum as asource ofcomplement (C) . Indirect PFC were developed with
rabbit anti-Fc of mouseIgG antiserum and C in assay preparations . Since the number of directPFC
wasnegligibly small in all the experiments, only the numbersof indirect PFC are listed in theResults .
Anti-8 Serum Treatment of PAB-MGG-Primed Splenic Lymphocytes .
￿
Anti-B C3H serum was
prepared by intraperitoneal immunization of 100 x 106 C3H/He thymocytes into AKR male mice
with 2 x 10 6 Bordetella pertussis vaccine . 1 and 2 wk after the last of three consecutive biweekly
immunizations, all mice were bled and the sera pooled . The anti-8 sera obtained lysed 95% of
thymocytes at a 1:64 dilution and 30-40% of spleniclymphocytes at a 1 :9 dilution in thepresence of C,T . HAMAOKA, U. YAMASHITA, T . TAKAMI, AND M. KITAGAWA
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as measured by trypan blue dyeexclusion test . Single spleen cell suspensions were treated with anti-6
serum and C as follows : Spleen cells taken from PAB-MGG-primed mice were suspended in 10% calf
serum-supplemented MEM at a concentration of 100 x 108 cells/0.5 ml . 1.0 ml of heat-inactivated
anti-BC3Hwas added to each such aliquot andthe mixture incubated at 4°C for30 min, washed, and
then resuspended in 0.5 ml of medium . 1 .0 ml ofguinea pigC (absorbed with normal mice spleen cells
and diluted 1:2 in medium) was added to each aliquot and themixtureincubated for an additional 40
min at 37°C . Viability of recovered cells was 90% and total recovery of viable cells after such
treatment was in the range of 50%.
Treatment of PAB-MGG-Primed Splenic Lymphocytes with Trypsin .
￿
Enzymatic treatment of
PAB-MGG-primed cells with trypsin was performed as follows : 30 x 108 cells were incubated for 20
min at 37°C in 1 ml of afreshly prepared solution containing 150 /Ag/ml trypsin and 10 gg/ml DNase
(Worthington Biochemical Corp ., Freehold, N. J.) in MEM. After trypsinization, the cells were
washed three times in MEM.
Statistical Analysis . The numbers of PFC per spleen were logarithmically transformed and
means and standard errors calculated . Group comparisons were made employingthe Student's t test .
In those mice in which no PFC could be detected in the spleen, a value of 240 per spleen was
arbitrarily assigned to allow logarithmic transformation of the data, the value corresponding to the
minimal number ofPFC detectable in our assay .
Results
Characterization of Hapten-Reactive Helper Activity Raised by the
Immunization of Hapten-Isologous Carrier Conjugates
It has been previously reported from our laboratory that hapten (DNP)-reac-
tive helper cells could be raised in mice by the immunization of hapten-isologous
protein conjugates (DNP-MGG) . Thus, DNP-specific B cells in the DNP-MGG-
primed spleen cells can easily respond to DNP-heterologous conjugates such as
DNP-HGG or DNP-KLH due to the presence of hapten-reactive helper cells
(reference 30 and footnote 2) . These hapten-reactive helper cells could be also
raised to another noncross-reactive hapten such as PAB by priming with
PAB-MGG, and in this case, cooperative interactions of PAB-reactive helper
activities could be demonstrated againstDNP-primed B cells as describedbelow.
DEVELOPMENT OF PAB-REACTIVE HELPER ACTIVITY IN MICE BY IMMUNIZATION OF
PAB-MGG .
￿
Three groups of mice were immunized intraperitoneally with 100 lug of
PAB-MGG, MGG, orPAB-HGG in CFA . 6 wk thereafter, those immunized mice
and another group of nonimmunized normal animals were X irradiated (600 R)
and then injected intravenously with spleen cells (50 x 10 11 ) from mice which had
been immunized with 100,ug ofDNP-BaA in CFA 10 wk previously . Immediately
before the cell transfer, those DNP-BaA-primed cells were stimulated in vitro
with 100 lag ofDNP-MGG-PAB . 7 days after the cell transfer, the anti-DNP PFC
responses ofDNP-BaA-primed cells were measured in therecipients' spleens and
the results are graphically depicted in Fig . 1 .
It can be seen in Fig . 1 that the DNP-BaA-primed cells did not respond to the
stimulation ofDNP-MGG-PAB in normal X-irradiated recipients, whereas these
cells responded to the stimulation ofDNP-MGG-PAB in the PAB-MGG-primed
X-irradiated recipient mice . Thus, the helper activity for the induction of
' Hamaoka, T ., T . Inada, U . Yamashita, and M. Kitagawa . 1975. Preventive effect of hapten-reac-
tive thymus-derived helper lymphocytes on the tolerance induction in hapten-specific precursors of
antibody-forming cells.J . Immunol . In press .1312
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FIG . 1 . Development of PAB-reactive helper activity by immunization with PAB-MGG .
Recipient mice were primed by intraperitoneal injection of either 100 fag ofPAB-MGG, MGG,
or PAB-HGG in CFA 6 wk before cell transfer. Those primed mice and other groups of
nonimmunized normal mice were X irradiated (600 R) and then injected intravenously with
DNP-BaA-primed spleen cells stimulated with 100 pg of DNP-MGG-PAB . The DNP-BaA-
primed spleen cells came from mice which had been immunized with 100 Ag of DNP-BaA in
CFA 10 wk previously . Geometric means and standard errors of anti-DNP PFC responses in
spleens of the recipients 7 days after the cell transfer are illustrated .
anti-DNP antibody response to the DNP-primed B cells by the stimulation of
DNP-MGG-PAB could be raised by the immunization of PAB-MGG in CFA.
This helper activity may be specific for the PAB portion of DNP-MGG-PAB .
The specificity restriction of the helper activity which arose from PAB-MGG
immunization may be suggested by the fact that such helper activity in
PAB-MGG-primed mice could not be replaced by the MGG immunization .
Moreover, PAB specificity of the helper activity was also reinforced by the fact
that (a) the DNP-primed B cells responded poorly or not at all to the stimulation
of DNP-MGG-PAB in recipient mice which had been immunized with MGG
conjugates similarily coupled with m- or o-azobenzoate, 3 and (b) the helper
activity induced by the immunization of PAB-MGG could be demonstrated to
the double hapten conjugate ofHGG (DNP-HGG-PAB), which is not cross-reac-
tive with MGG. 4 The possibility that this helper activity was mediated by,
anti-PAB antibody or B cells themselves was ruled out by the following two
observations . (a) The effective cell population in PAB-MGG-primed mice was
radioresistant (31) . (b) The helper activity was not observed in PAB-HGG-
'Yamashita, U ., T. Hamaoka, T . Takami, and M . Kitagawa . Immunological maturation in T
lymphocytes : sequential changes in specificities and affinities of hapten-reactive helper T cells during
the immune course . Manuscript in preparation .
' Yamashita, U ., T . Takami, T . Hamaoka, and M . Kitagawa . Termination of immunological
tolerance to human gamma globulin in mice by hapten-reactive helperT lymphocytes . Manuscript in
preparation .T . HAMAOKA, U . YAMASHITA, T . TAKAMI, AND M . KITAGAWA
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primed mice at the challenge of DNP-MGG-PAB . The nature and specificity
restrictions of helper activity developed in mice by the immunization of
PAB-MGG were next explored more definitively .
SUSCEPTIBILITY OF HELPER CELL ACTIVITY DEVELOPED BY PAB-MGG IMMUNIZATION
TO THE TREATMENT OF ANTI-6 SERUM PLUS C . In order to assess the nature of
helper activity developed by the immunization of PAB-MGG, the classical
double-cell transfer system was employed to measure helper activity oflymphoid
cells from PAB-MGG-primed donor mice to DNP-primed B cells, with examina-
tion of the susceptibility of helper activity of the PAB-MGG-primed lymphoid
cells to the treatment of anti-B serum plus C.
Spleen cells (40 x 106) from mice which had been immunized intraperitoneally
with 100 mg of DNP-KLH in CFA 6 wk previously were used as a DNP-primed
B-cell source . Spleen cells (50 x 10 6) from other donor mice which had been
immunized intraperitoneally with 100 lugofPAB-MGG 7wk previously were used
as PAB-MGG-reactive helper cells . The PAB-MGG-primed spleen cells were
treated with either normal mouse serum (NMS) plus C or anti-B serum plus C
before the cell transfer, mixed together with the DNP-KLH-primed cells, and
then transferred into X-irradiated (550 R) recipients after antigenic stimulation
with 100 gg of DNP-MGG-PAB .
As a control for the nonspecific effect of anti-B serum treatment on the primed
cells being transferred, theDNP-KLH-primed cells were also treated in a similar
fashion with NMS or anti-9 serum plus C and stimulated with 100 Fig of
DNP-KLH or DNP-BaA in the presence of BaA-primed spleen cells (50 x 106) .
These BaA-primed cells came from other donor mice which had been immunized
intraperitoneally with 100 Ng of BaA in CFA 6 wk previously . All the recipients
were killed 7 days after secondary challenge . Anti-DNP PFC responses in the
recipient spleens are summarized in Table I.
The DNP-KLH-primed cells which were treated withNMS plus C elicited, as
expected, high levels of anti-DNP PFC responses after antigenic challenge with
DNP-KLH (group VI), whereas the adoptive secondary response was almost
completely abolished in the recipients of cells treated with anti-B serum plus C
(group VII) . In contrast, the addition of BaA-primed cells restored the capacity
of recipients of anti-B serum-treated DNP-KLH-primed cells to develop an
anti-DNP antibody response (groups IV and V) . The recipients of DNP-KLH-
primed cells which were challenged with DNP-MGG-PAB developed meager
responses (group I) unless PAB-MGG-primed cells were administered in addi-
tion, in which cases the secondary responses were very significantly augmented
(group II) . Anti-B serum treatment of these PAB-MGG-primed cells, however,
virtually abrogated this adoptive secondary response to DNP-MGG-PAB (group
III) . Thus, these results clearly demonstrated that the helper cells developed by
immunization with PAB-MGG are 0-positive T lymphocytes.
SUPPRESSION OF HELPER ACTIVITY DEVELOPED BY PAB-MGG IMMUNIZATION BY
TREATMENT WITH PAB-D-GL . In order to further assess thespecificity restriction of
the helper T-cell activity developed by PAB-MGG immunization, an attempt
was made to suppress the PAB-MGG-primed helper T cells by treatment with
PAB-D-GL . If the reactivity ofPAB-MGG-primed helper T cells are suppressed1314 TOLERANCE IN T LYMPHOCYTES . I
TABLE I
Susceptibilitv of Helper Cell Activity Deueloped by PAB-MGG Immunization to
Treatment with Anti-6 plus C*
*40 x 10 6 spleen cells from donor mice, primed 6 wk earlier with 100 hg ofDNP-KLH in CFA, were
used as DNP-primed cells, and they were nontreated (groups I - III) or treated in vitro with either
anti-B serum plus C or NMS plus C (groups IV - VII) . They were then transferred intravenously
into 550R X-irradiated recipients either alone or together with PAB-MGG-primed or BaA-primed
spleen cells . The PAB-MGG-primed spleen cells had been also treated in vitro with NMS plusC or
anti-B serum plusC. The PAB-MGG-primed cellsand BaA-primed cellscame from mice which had
been immunized in CFA 7 wk and 6 wk before the cell transfer, respectively . Secondary antigenic
challenges were performed in vitro by mixing those primed cells with 100 leg of hapten-carrier
conjugates, as indicated, immediately before the cell transfer .
$ The data are expressed as geometric means of anti-DNP PFC in the recipient spleens 7 days after
the cell transfer . Numbers in parentheses represent standard errors . Statistical comparison of the
mean PFC responses in various groups yielded the followingPvalues : group II vs . III, P< 0.001 ; IV
vs . V, 0.10 < P < 0.20 ; and VI vs . VII, P < 0.001 .
by that treatment, one may conclude that the PAB-MGG-primed helper T cells
are specific for PAB groups, since the helper cells will only interact with the PAB
portion of PAB-n-GL .
Two groups of animals were immunized intraperitoneally with 100 leg of
PAB-MGG in CFA 8 wk previously . One of the groups received 1 mg of
PAB-D-GL intraperitoneally and the other received saline . 4 days later, they were
then X irradiated (600 R) and injected with 50 x 108 spleens cells from mice
which had been immunized with 100 pg ofDNP-BaA in CFA 9 wk before, as the
DNP-primed B-cell source . Antigenic stimulation to the DNP-BaA-primed cells
was given by mixing those primed cells with 100,ug of DNP-MGG-PAB in vitro
before the cell transfer . As a control for the background response ofDNP-BaA-
primed cells to the DNP-MGG-PAB, the same pool of primed cells with antigen
was also transferred into nonimmunized X-irradiated mice . Anti-DNP responses
in recipients 7 days after the cell transfer are depicted graphically in Fig . 2 .
It is evident that the helper T-cell reactivity in PAB-MGG-primed mice was
significantly suppressed by pretreatment with PAB-D-GL, as assessed by the
reduction of the anti-DNP antibody responses in the PAB-n-GL-pretreated
recipients .
This result indicates that the specificity of most of the PAB-MGG-primed
helper T cells may be directed against PAB haptenic sites, and this PAB-reactive
Group
Treatment of
DNP-KLH-
primed cells
with :
Helper cell source Secondary
challenge
Anti-DNP
antibody
response$
PFC/spleen
I None None DNP-MGG-PAB 376(l.18)
II None NMS-treated PAB-MGG-cells DNP-MGG-PAB 19,271 (1.06)
III None Anti-0-treated PAB-MGG cells DNP-MGG-PAB 605 (1.26)
IV NMS plus C BaA-primed cells DNP-BaA 25,538 (1 .13)
V Anti-B plusC BaA-primed cells DNP-BaA 15,866 (1 .12)
VI NMS plus C None DNP-KLH 61,766 (1.08)
VII Anti-B plus C None DNP-KLH 1,807 (1.06)T . HAMAOKA, U . YAMASHITA, T . TAKAMI, AND M . KITAGAWA
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FiG. 2 . Suppression of helper activity developed by PAB-MGG immunization by the
treatmentwith PAB-D-GL . 50 x 10° spleen cells from donormice which had been immunized
with 100 ug of DNP-BaA in CFA 9 wk previously were transferred intravenously into three
groups of X-irradiated recipient mice together with 100 kg of DNP-MGG-PAB . One of the
groups represents normal nonimmunized recipients and the other two represent those
immunized with 100 Ag ofPAB-MGG in CFA 8 wk previously, then treated intraperitoneally
with either 1 mg of PAB-D-GL or saline 4 days before the cell transfer . Anti-DNP PFC
responses in recipient spleens 7 days after cell transfer are illustrated . Closed squares represent
the level of anti-DNP-PFC responses in normal nonimmunized recipients . Statistical
comparison of the responses of saline-treated andPAB-D-GL-treated animals yielded aPvalue
of 0.02 < P < 0.025 .
helper T-cell activity could be easily suppressed by interaction withPAB-D-GL .
In the above sections, we have demonstrated that PAB-reactive helper T
lymphocytes were developed in mice by immunization of PAB-MGG, and that
these helper activities were significantly suppressed by the treatment of
PAB-D-GL . If the suppression of the reactivity of PAB-reactive helper T cells by
PAB-D-GL treatment, as demonstrated above, had been established on a level of
educated helper T lymphocytes, then this PAB-D-GL system may provide a
potential advantage over other models for analysis of tolerance induction on the
T-cell level since, in general, educated T lymphocytes are difficult to tolerize by
the tolerogen treatment . Nevertheless, delineation of cellular events in this
phenomenon requires sufficient quantities of specific helper T cells for any such
study to be meaningful . In the following section, wehave attempted to assess this
point directly by using the double-cell transfer system of DNP-specific B cells
and PAB-reactive T cells .
Induction of Unresponsiveness of PAB-Reactive Helper T Cells with
PAB-D-GL Given to PAB-MGG-Primed Donor Mice
Two groups of donor mice, immunized 10 wk previously with 100 Ag of
PAB-MGG in CFA, were pretreated with saline or 1 mg of PAB-D-GL1316
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intraperitoneally 4 days before the cell transfer . The spleen cells (50 x 10 6 ) from
those two groups were mixed with DNP-BaA-primed spleen cells (50 x 106) from
other donor mice which had been immunized intraperitoneally with 100 Ag of
DNP-BaA in CFA 9 wk earlier . They were then stimulated with 100 pg of
DNP-MGG-PAB and transferred intravenously into two groups of X-irradiated
(550 R) recipient mice . Another two irradiated recipients were also injected with
the same DNP-BaA-primed cells alone, and then similarly stimulated with 100
Ag ofDNP-MGG-PAB or DNP-BaA as a background or positive control response
of those primed cells . Anti-DNP antibody responses in the recipient spleens were
measured 7 days after the cell transfer .
As shown in Table 11, DNP B cells in the DNP-BaA-primed cell population
TABLE 11
Induction of Unresponsiveness in PAB-Reactive Helper T Cells with PAB-D-GL*
PAB-MGG-primed cells
* 50 x 10 6 spleen cells from mice which had been immunized with 100 ug ofDNP-BaA in CFA 9wk
previously were transferred intravenously into X-irradiated (550 R) recipient mice either alone or
together with PAB-MGG-primed cells from donor mice immunized 10 wk earlier and pretreated
intraperitoneally with either saline or 1 mg PAB-D-GL 4 days before the cell transfer . Secondary
challenges were performed by mixing them with 100 jug of hapten-carrier conjugates, as indicated,
immediately before the cell transfer . Anti-DNP PFC responses in recipient spleens 7 days after the
cell transfer are listed . Statistical comparison of the responses of saline-pretreated and PAB-v-GL-
pretreated helper T cells yielded aP value of 0.001 < P < 0.005 .
responded nicely to DNP-BaA but did not respond to DNP-MGG-PAB, as
expected . When the DNP-BaA-primed cells were stimulated with DNP-MGG-
PAB in the presence of PAB-MGG-primed cells from saline- or PAB-n-GL-
treated donors, it was found that PAB-reactive helper activities of PAB-MGG-
primed cells which were pretreated with PAB-D-GL in the donor mice were
significantly lower than the saline-treated group . These results clearly indicate
that the responsiveness of PAB-reactive helper T cells was suppressed by the
pretreatment of PAB-D-GL in donor mice, and this suppressive state of helper T
cells did not revert to normal after adoptive cell transfer into other recipients .
The specificity of suppression induced by PAB-D-GL pretreatment is evident
from the results shown in Fig . 3 . In this experiment, the protocol for which is
shown in the left panel of Fig . 3, two groups of donor mice which had been
immunized with 100 Fig of DNP-BaA in CFA 6 wk previously, were injected
intraperitoneally with 1 mg of PAB-D-GL or not treated . 4 days after such
treatment, the spleen cells (50 x 10 6) from respective donor mice were transferred
into two groups of X-irradiated (550 R) recipient mice and stimulated with 100 leg
DNP-primed
cells PAB-reactive helperTcells Secondary
challenge
Anti-DNP anti-
body response
PFC/spleen
DNP-BaA None DNP-BaA 80,974 (1.22)
DNP-BaA None DNP-MGG-PAB 240(l.0)
DNP-BaA 4days saline-pretreated DNP-MGG-PAB 13,718 (1.13)
PAB-MGG-primed cells
DNP-BaA 4 days PAB-n-GL-pretreated DNP-MGG-PAB 1,747 (1.32)1317
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Specificity of PAB-D-GL-induced tolerance in PAB-reactive helperTlymphocytes . 50
x 10 6 spleen cells from donor mice which had been immunized with 100 Ag of DNP-BaA in
CFA 6 wk previously were transferred intravenously into X-irradiated (550 R) recipient mice
either alone or together with 50 x 10° KLH-primed, OVA-primed, or PAB-MGG-primed
spleen cells . These helper cells came from other donor mice which had been immunized with
100 jug of KLH, OVA, and PAB-MGG in CFA 7, 6 and 8 wk before the cell transfer,
respectively . As demonstrated in the left panel, these DNP-primed cells and helper cells were
either nontreated or pretreated intraperitoneally with 1 mg PAB-D-GL 4 days before the cell
transfer . Secondary antigenic challenges were performed with 100 Ag of various hapten-carrier
conjugates as indicated . Anti-DNP antibody responses in recipients 7 days after the cell
transfer are illustrated . Statistical comparisons of the means among nontreated and
PAB-D-GL-pretreated groups in DNP-BaA-primed, KLH-primed, OVA-primed, and PAB-
MGG-primed cells yielded, 0.10 < P < 0.20, 0.70 < P < 0.80, 0.50 < P < 0.60, andP <
0.001, respectively .
of DNP-BaA. In another six groups of mice, the DNP-BaA-primed cells (50 x
106) from the same nontreated donor pool were transferred together with 50 x 106
KLH-primed, OVA-primed, or PAB-MGG-primed spleen cells which had been
either not treated or pretreated intraperitoneally with 1 mg ofPAB-D-GL 4 days
previously . The recipients were then stimulated with 100 ug of DNP-KLH,
DNP-OVA, and DNP-MGG-PAB, respectively . The above carrier-primed cells
were obtained from mice which had been immunized 7 wk (KLH), 6 wk (OVA),
and 8 wk (PAB-MGG) before the cell transfer, respectively . All the recipients
were killed 7 days after the cell transfer and anti-DNP antibody responses of
those DNP-BaA-primed cells were measured .
It is immediately evident from the results shown in the right panel of Fig . 3
that the pretreatment ofPAB-D-GL specifically suppresses the responsiveness of
PAB-reactive helper T cells, while other helper T-cell activities of various
specificities such as to BaA, KLH, or OVA, were not suppressed significantly by
the pretreatment of PAB-D-GL .
Evidences for an Intracellular Mechanism ofInactivation of
PAB-Reactive Helper T Cells by the Treatment of PAB-D-GL
In the above experiments, we were able to induce specific suppression of
PAB-reactive helper T cells by administration of PAB-D-GL to the PAB-MGG-
primed mice . A unique feature of this model is the relative ease with which the
T . HAMAOKA, U . YAMASHITA, T . TAKAMI, AND M . KITAGAWA
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suppression can be established in the educated T lymphocytes . As possible
mechanisms of the specific suppression by treatment with PAB-D-GL, the
following possibilities are conceivable: (a) During the 4-day period ofPAB-D-GL
treatment, the suppressor cell activity of PAB specificity may be generated in
PAB-MGG-primed animals, with those suppressor cells imparting suppressive
influences to the cellular cooperation of DNP-primed B cells with PAB-reactive
helper T cells upon stimulation with DNP-MGG-PAB; and (b) PAB-D-GL does
not suppress the PAB-reactive helperT cells themselves but simply binds to and
blocks the T-cell receptor sites, thereby ultimately inhibiting effective cellular
cooperation between DNP-primed B cells and PAB-reactive helper T cells .
Finally, (3) PAB-D-GL specifically binds to T-cell receptor sites and inactivates
the PAB-reactive helper T lymphocyte through some intra- or subcellular
mechanism . The following series of experiments were performed to study these
possibilities .
ELIMINATION OF THE POSSIBILITY OF CARRY-OVER OF TOLEROGEN OR GENERATION
OF SUPPRESSOR CELLS AS THE EXPLANATION FOR THE SUPPRESSION OF PAB-REACTIVE
HELPER CELLS BY PAB-D-GL . In order to determine whether suppressor activity
can be detected in the PAB-MGG-primed cells which had been exposed to
PAB-D-GL in donor mice, PAB-D-GL-pretreated PAB-MGG-primed cells were
added to the PAB-reactive helperT cells from nontreated donors and the effect of
this addition on helper T-cell activity was studied .
Spleen cells from mice which had been immunized intraperitoneally with 100
Ag of DNP-B«A in CFA 12 wk previously were used as a DNP-primed B-cell
source and transferred into five groups of X-irradiated (550 R) recipient mice
either alone or together with PAB-MGG-primed spleen cells . The PAB-MGG-
primed cells came from mice which had been primarily immunized 9 wk
previously and boosted 5 wk before, then treated intraperitoneally either with 1
mg of PAB-D-GL or saline 3 days before sacrifice .
As shown in the protocol in Table III, which is substantially the same as in
TABLE III
Failure to Detect SuppressorActivity in PAB-D-GL-PretreatedPAB-MGG-Primed Cells*
*The experimental protocol is substantially the same as Table II . DNP-BaA-primed cells came from
mice whichhadbeen immunized 12 wk previously andPAB-MGG-primed cells from mice primarily
immunized 9 wk previously and boosted 5 wk before . Statistical comparison of the mean PFC
responses in various groups yielded the followingPvalues : group II vs . III,P < 0.001 ; III vs . IV, P <
0 001- III vs . V, 0.60 < P <0.70 .
DNP-primed
cells Group PAB-reactive helperT cells Secondary
challenge
Anti-DNP anti-
body response
PFC/spleen
DNP-BaA I None DNP-BaA 452,894 (1.07)
DNP-BaA II None DNP-MGG-PAB 460 (1.61)
DNP-BaA III 3 days saline-pretreated DNP-MGG-PAB 701,878 (1.23)
PAB-MGG-primed cells (A)
DNP-BaA IV 3 days PAB-D-GL-pretreated DNP-MGG-PAB 776 (1.59)
PAB-MGG-primed cells (B)
DNP-BaA V (A) + (B) DNP-MGG-PAB 519,694 (1.08)T . HAMAOKA, U . YAMASHITA, T . TAKAMI, AND M. KITAGAWA 1319
Table II, Groups I and II received DNP-BaA-primed cells alone and were then
stimulated with 100 lug of DNP-BaA or DNP-MGG-PAB . Groups III and IV
received DNP-BaA-primed cells together with PAB-MGG-primed cells which
had been either pretreated with saline or PAB-D-GL 3 days before the cell
transfer . Group V received a mixture of equal numbers of both types of
PAB-MGG-primed cells. They were then all stimulated with 100 jug of DNP-
MGG-PAB. Anti-DNP antibody responses were measured in recipient spleens 7
days after the cell transfer, and the results are summarized in Table III .
In comparison of group II with group III, the PAB-reactive helper (T) cells in
the PAB-MGG-primed cell population nicely helped the anti-DNP-antibody
response of DNP-primed B cells in the DNP-BaA-primed cell population at the
stimulation of DNP-MGG-PAB. On the other hand, as shown in group IV, the
pretreatment of PAB-D-GL to those PAB-MGG-primed cells almost completely
abrogated such activities . Most importantly, however, when those PAB-MGG-
primed cells whose responses had been suppressed by PAB-D-GL pretreatment
were added to the above intact PAB-reactive helper T cells (group V), the
magnitude of response of those mixtures of PAB-reactive helper cells was almost
at the same level as in group Ill . This result, therefore, argues strongly against
the possibility that the PAB-MGG-primed cells which had been exposed to
PAB-D-GL afford some suppressive influences either to the PAB-reactive helper
cells or to the DNP-specificB cells . This further indicates that, in this tolerance
model onthe helper T-cell level, PAB-D-GL renders the helperTcells themselves
unresponsive . Suppressor factors such as suppressor cells, or the carry-over of
some PAB-D-GL with the transferred cell populations seem not to operate in the
mechanism of this unresponsiveness of PAB helperT cells .
EVIDENCE THAT TOLERANCE INDUCED BY PAB-D-GL IS NOT MERELY REFLECTIVE OF
BLOCKING OF SURFACE RECEPTORS ON T LYMPHOCYTES . In order to test the
possibility that PAB-D-GL simply binds to and blocks the T-cell receptor sites
and thereby ultimately inhibits cellular cooperation, PAB-D-GL was directly
exposed in vitro at 4°C for 1h to PAB-reactive helper T lymphocytes, conditions
in which PAB-D-GL is supposed to bind to the PAB-reactive T lymphocytes .
Helper activity of these PAB-reactive T cells after exposure to PAB-D-GL was
measured by the double cell transfer system of cellular cooperation with
DNP-primed B cells, as described below.
Spleen cells (50 x 108) from mice which had been immunized intraperitoneally
with 100 lug ofDNP-BaA in CFA 15 wk previously were used as the DNP-primed
B-cell source and transferred intravenously into X-irradiated (550 R) recipients
alone or together with PAB-MGG-primed spleen cells (50 x 10 8) from mice which
had been immunized intraperitoneally with 100 lug of PAB-MGG in CFA 10 wk
previously .
As shown in the experimental protocol in Table IV, DNP-BaA-primed cells
were stimulated with 100 jug of DNP-BaA as a positive control of the
responsiveness ofDNP-primed B cells (group I), and with 100 Ag ofDNP-MGG-
PAB in the absence or presence of PAB-MGG-primed helper T lymphocytes
(groups II and III) . In groupIV, the PAB-reactive helper T cells transferred came
from PAB-MGG-primed mice which had been pretreated intraperitoneally with1320 TOLERANCE IN T LYMPHOCYTES. I
TABLE IV
Failure to Suppress Reactivity of PAB-Reactive Helper T Cells when Exposed to
PAB-D-GL In Vitro Immediately before the Cell Transfer*
* The experimental protocol is substantially the same as Table II except in groups V - VIII, in which
various doses of PAB-D-GL were mixed in vitro with PAB-reactive helper T cells (50 x 108) and
incubated at 4°C for 1 h before the cell transfer. Donors of DNP-primed cells and PAB-reactive
helper T cells came from mice primed with 100 Mg of DNP-BaA in CFA 15 wk earlier and PFC
responses between group III vs. IV, V, VI, VII, and VIII yielded P values ofP < 0.001, 0.30 < P <
0.40, 0.70 < P < 0.80, 0.80 < P < 0.90, and 0.10 < P < 0.20, respectively.
1 mg of PAB-D-GL 4 days before the cell transfer. It is again evident that the
reactivity of PAB-reactive helper T cells (group IV) was effectively suppressed by
pretreatment with PAB-D-GL, as compared with saline-pretreated helper cells
(group III) .
In sharp contrast, however, when the PAB-MGG-primed cells (50 x 106) were
exposed in vitro to various concentrations (0.01 p,g - 10 gg) of PAB-D-GL for 1 h
at 4°C, mixed together with DNP-BaA-primed cells without washing, and then
stimulated with 100 ug of DNP-MGG-PAB (groups V - VIII), the PAB-reactive
helper T-cell activity in the PAB-MGG-primed cell population was not sup-
pressed within the range of concentrations of 0.01-1.0 pg (groups V - VII), and
only slightly at 10 gg of PAB-D-GL (group VIII).
Thus, PAB-D-GL when added in vitro to PAB-reactive helper T cells does not
suppress the reactivity of those helper T cells. These results suggest that the
suppression of PAB-reactive helper T cells induced in vivo by exposure to
PAB-D-GL, such as was demonstrated in group IV, may not be due solely to the
blocking of T-cell receptors. Although this failure to suppress the PAB-reactive
helper T-cell activity when incubated in vitro with PAB-D-GL argues against a
predominant surface mechanism, it fails to provideformal evidence on this point.
The following experiment was designed and carriedout to explorethis point more
completely .
FAILURE TO REVERSE TOLERANCE INDUCED IN VIVO WITH PAB-D-GL BY TRYPSINI-
ZATION OF CELLS BEFORE ADOPTIVE TRANSFER TO IRRADIATED RECIPIENTS . The sec-
ond approach to the question of receptor blocking by tolerogen took advantage
of capacity of enzymatic treatment of cell surfaces by trypsin to reverse toler-
DNP-primed
cells
Group
PAB-reactive helper T cells
treated with:
Secondary
challenge
Anti-DNP
antibody
response
PFC/spleen
DNP-BaA I None DNP-BaA 145,237 (1.05)
DNP-BaA II None DNP-MGG-PAB 2,227 (1.05)
DNP-BaA 111 4 days saline-pretreated in vivo DNP-MGG-PAB 109,433 (1.16)
DNP-BaA IV 4 days PAB-D-GL-pretreated in vivo DNP-MGG-PAB 12,262 (1.12)
DNP-BaA V PAB-D-GL mixed in vitro, 0.01 jig DNP-MGG-PAB 138,723 (1.12)
DNP-BaA VI PAB-D-GL mixed in vitro, 0.1 Wg DNP-MGG-PAB 103,595 (1.11)
DNP-BaA VII PAB-D-GL mixed in vitro, 1.0 leg DNP-MGG-PAB 103,299 (1.16)
DNP-BaA VIII PAB-D-GL mixed in vitro, 10 leg DNP-MGG-PAB 70,933 (1.24)T . HAMAOKA, U. YAMASHITA, T. TAKAMI, AND M . KITAGAWA
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ance induced by PAB-D-GL . The validity of this approach was based on the
previous findings (12) in tolerance induction of B cells by DNP-D-GL that the
trypsin treatment of B cells exposed to DNP-D-GL for a relatively short time
could clearly reverse the tolerance state to normal, whereas trypsinization of
cells exposed to DNP-D-GL for a longer period of time did not reverse the toler-
ance to responsiveness . This formed a strong basis for our notion that binding of
tolerogen on the surface ofB lymphocytes for a certain period of time results in
functional inactivation of B lymphocytes . In the following experiment, we ap-
plied this same reasoning to T-cell tolerance in the PAB-D-GL model.
The protocol of this experiment is schematically depicted in the left panel of
Fig. 4. Briefly, two groups of donor mice which had been primed with 100 Ag of
Saline
Pretreated
PAB- D- GL
Pretreated
FAG. 4 .
￿
Failure to reverse tolerance induced in vivo with PAB-D-GL by trypsinization of cells
before adoptive transfer. PAB-MGG-primed cells were obtained from mice which had been
primed 9 wk earlier, boosted5wk earlier, then pretreated intraperitoneally with saline or 1 mg
PAB-D-GL 3 days before sacrifice . DNP-BaA-primed cells came from mice immunized 16 wk
previously . Relevant statistical comparisons of responses yielded the followingPvalues : (a)
nontrypsinized saline controls vs . nontrypsinized PAB-n-GL-pretreated cells, P < 0.001 ; (b)
trypsinized saline controls vs . trypsinized PAB-n-GL-pretreated cells, 0.001 <P< 0.005 ; (c)
nontrypsinized saline controls vs . trypsinized saline controls, 0.50 < P < 0.60 ; and (d)
nontrypsinized PAB-n-GL-pretreated cells vs . trypsinized PAB-n-GL-pretreated cells, P <
0.001 .
PAB-MGG in CFA 9 wk earlier and boosted with the same dose 5 wk before
sacrifice, were pretreated intraperitoneally with 1 mg of PAB-D-GL or saline .
After 3 days, spleen cells from these two groups of mice were obtained and
washed three times with MEM. Each pool was divided into two samples, one of
which was left untreated while the second was treated with trypsin, as outlined
in the Materials and Methods . Groups of irradiated (550 R) recipient mice were
injected intravenously (50 x 106 cells/mouse) with either untreated or trypsinized
cells from the respective donor mouse groups ; these cells were mixed together
with 50 x 106 DNP-BaA-primed spleen cells which came from other donor mice
which had been immunized 16 wk earlier with 100 gg of DNP-BaA in CFA. The
mixture of those primed cells was then secondarily challenged with 100 jug of
PAB-MGG-Primed Cells
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w 700
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DNP-MGG-PAB. All the recipients were bled 7 days later and anti-DNP anti-
body responses were measured .
As shown in the right panel of Fig. 4, PAB-reactive helper T cells exposed to
saline in the donor mice elicited very good adoptiveanti-DNP antibody responses
with the DNP-primed B cells upon stimulation by DNP-MGG-PAB; trypsiniza-
tion barely, and not significantly, reduced or augmented these responses. In
contrast, the helper cells which had been exposed to PAB-D-GL failed to induce
cellular cooperation to the stimulation of DNP-MGG-PAB, and this inability to
induce cellular cooperation was not reversed by trypsinization, even though
trypsinization of such cells resulted in a slight increase in magnitude of these re-
sponses.
Since trypsin presumably removes surface receptors (and any associated
tolerogen) these results indicate that : (a) a partial improvement of the reactivity
of PAB-D-GL-pretreated helper cells after trypsinization may reflect some degree
of unblocking of surface receptor molecules by PAB-D-GL ; and (b) the ultimate
failure of trypsinization to reverse unresponsiveness of PAB-D-GL-pretreated
cells to normal levels must, by analogy, reflect more complex inhibitory events
not predominantly related to reversible surface membrane factors .
Discussion
Treatment of thePAB derivative of the copolymer of D-GL induces a profound
state of unresponsiveness to PAB-reactive helper T lymphocytes present in
PAB-MGG-primed mice . A unique feature of the PAB-D-GL tolerance model as
presented in these studies is the relative ease with which tolerance can be
specifically induced to the PAB-primed helperT lymphocytes. This may provide
a potential advantage over other models of tolerance on the T-cell level since, in
general, primedT lymphocytes are difficult to tolerize by tolerogen treatment . In
the present studies, wehave taken advantage of those features to analyse possible
mechanisms for tolerance induction on the level of helper T cells.
Thus, spleen cells from PAB-MGG-primed donor mice which contain PAB-
reactive helperT cells normally induce very good cooperative adoptive secondary
anti-DNP antibody responses to DNP-primed B cells when stimulated with a
double hapten-carrier conjugate coupled with mutually noncross-reacting DNP
and PAB haptens (Fig. 1 and Table I) . However, exposure of such PAB-primed
helper T cells to PAB-D-GL completely, or almost completely, abolished the
helper activity of those primed cells (Fig . 2 and Table II) . This induction of
unresponsiveness was specific for the PAB-reactive helper T cells, since such
treatment did not have any influence on the responsiveness of BaA-, KLH-, or
OVA-primed helper T lymphocytes (Fig . 3) .
In view of detailed studies by Chiller et al . (3, 4) on thekinetics of tolerance induction to
deaggregated HGG, it is well established that induction of tolerance to thymus-dependent
antigens clearly involves the establishment oftolerance in both T andB lymphocytes, the
former being rendered tolerant much more rapidly and with a lower concentration of
antigen . On the basis of what is known aboutthe operational differences betweenT andB
lymphocytes, establishment ofamodel in which tolerance is restricted to B or Tcells may
be very crucial for elucidation of the mechanism oftolerance induction in each cell type . In
the previous studies (9, 10, 12), it has been shown that administration of the DNPT. HAMAOKA, U. YAMASHITA, T. TAKAMI, AND M . KITAGAWA 1323
derivative of the copolymer OfD-GL to inbred mice induces a profound state oftolerance to
DNP-primed B cells in such aminals immunized with DNP-heterologous protein
conjugates such as DNP-KLH . Both the maintenance of tolerance ofDNP-specific B cells
by serial adoptive transfer (9) and the failure to reverse tolerance by trypsin treatment of
tolerized DNP-specific B cells (12) indicate that the mechanism of tolerance induction on
the B-cell lineage is the specific inactivation or elimination of clones by the tolerogen, and
cannot be explained solely by simple masking of tolerogen onto the B cells .
On the other hand, concerning the mechanism of tolerance induction in the T-cell
lineage, similar mechanisms may conceivably be operating, but this issue is unfortunately
still a point of controversy . The following three possibilities may be relevant to consider
with reference to the mechanism of induction of unresponsiveness in the T-cell
population : (a) Tolerance is mediated by a suppressor T-cell effect, since tolerance in
certain situations is infectious and the cells from tolerant donors have the ability to inhibit
antibody production of nontolerant cells due to an active suppressor T-cell effect in the
tolerant cell population (17-20) ; (b) tolerance is mediated by circulating suppressive
factors since, in another type oftolerance model such as is observed in unresponsiveness to
tissue-associated antigens, the lymphoid cells obtained from unresponsive animals have a
capacity to respond to that antigen when tested in a milieu free of serum from tolerant
animals (21-24) . Especially in this case, this cellular unresponsiveness can be reproduced
by addition of blocking serum factor . (c) Tolerance implies the specific elimination of
clones induced by tolerogen treatment, since some other types of evidence so far reported
also imply that tolerance in the T-cell population reflects deletion of a specific clone of
antigen-reactive T cells (25-27) . In this case, the tolerance is neither infectious nor
inducible by the administration of serum from tolerant animals, and is stable on adoptive
transfer . Thus, in contrast to tolerance induction in B lymphocytes, the precise
mechanism of T-cell tolerance is as yet unresolved. A critical question in any model of
T-cell tolerance concerns the mechanism by which suppression ofT-cell reactivity occurs .
Specifically, what happens to a tolerant T cell? Does it exist in a functionally
unresponsive or unrecognizable state, or is it eliminated from the system? Much of this
confusion stems from the apparently contradictory observations described above . This is a
crucial issue since on its rests the correct interpretation of the fate of tolerant T cells .
In the context of the above considerations, we have tried to analyse the mechanism of
tolerance induction and the fate of tolerant T cells in the PAB-D-GL model . One
immediate question that arises concerns the possibility that suppression of the reactivity
of PAB-reactive helperT lymphocytes in the PAB-D-GL model is mediated by suppressor
factors present in tolerant animals . That these suppressor factors exist has been
immediately ruled out by the following observations here reported : (a) The stability ofthe
unresponsiveness of helper T cells after transfer into other recipients from tolerogen-
treated donors where profound unresponsiveness was induced by PAB-D-GL (Table II) . If
mediation by a blocking factor in serum (or circulating tolerogen) alone is responsible for
the helper T-cell tolerance, one might expect that the unresponsiveness of helper T cells
from PAB-D-GL treated donors would be reversed after transfer into other recipient mice .
(b) More importantly, suppression of the reactivity of nontolerant helper T cells by
addition of tolerogen-treated helper T cells could not be induced (Table III) . In this case,
tolerogen-treated helper T cells almost completely lost their reactivity, but nevertheless
failed to show any suppressive influences on the reactivity of other nontolerant helper T
cells . This observation also rules out the possibility that maintenance of tolerance after
adoptive transfer into other recipients was due to carry-over of tolerogenic doses of
PAB-D-GL associated with the transferred cell populations . Thus, taken collectively,
these observations clearly indicate that suppression of PAB-reactive helper T cells was
induced by direct interaction of PAB-D-GL with PAB-reactive helper T cells themselves,1324
￿
TOLERANCE IN T LYMPHOCYTES . I
and that the treatment of tolerogen does not generate any suppressor factor responsible for
the unresponsiveness of T cells in this PAB-D-GL model . Furthermore, from the
experiment of in vitro exposure of PAB-D-GL to the PAB-reactive helper T lymphocytes
(Table IV), the possibility of a simple blocking of receptor molecules on the surface ofT
lymphocytes by tolerogen could be eliminated as an explanation for the suppression of
reactivity of helper T cells, and this points emphatically to the existence of a central
intracellular mechanism of specific tolerance induction on the T-cell level . The most
conclusive evidence that PAB-D-GL tolerance involves more sophisticated events than
receptor blockade derives from the failure of enzymatic treatment by trypsin of cells
tolerized by PAB-D-GL to reverse, or even diminish, the level of unresponsiveness
manifested by such cells (Fig . 4) . If these cells still had been capable of responding to PAB
but could not do so because all of their surface receptors were competitively blocked by
PAB-D-GL, then this situation should have been corrected by trypsinization . Indeed, a
slight recovery of responsiveness observed after trypsin treatment may suggest that such a
mechanism operates to some extent on the suppression of the activity of helper T-cell
function, though the prediction still seems valid that unresponsiveness of this type is
probably very transient in nature . Also evident from this result is that the ultimate failure
of trypsinization to reverse the unresponsiveness induced by PAB-D-GL clearly supports
the conclusion that such cells have been inactivated via sub- or intracellular mechanisms .
A tolerant state of this type would be predictably long lasting . We should emphasize,
however, that the concept of irreversibility as used here pertains to the individual T cells
which have been exposed to the tolerogen and not necessarily to the furture progeny of the
stem cell clone-bearing specificity for the tolerogen .
Since, as we have demonstrated, tolerance induced by PAB-D-GL is appar-
ently restricted to the PAB-reactive helper T lymphocytes, this model for
tolerance may be very informative with respect to an understanding of the
mechanism of tolerance induction in T lymphocytes . However, concerning the
tolerance induction of T lymphocytes by hapten D-GL conjugates, there are some
previously reported controversial observations . These involve the experiments of
hapten-specific tolerance induction in guinea pigs or mice . In guinea pigs, Cohen
et al . (32) reported that animals tolerized with DNP-D-GL, although manifesting
a marked depression in the humoral response after immunization with DNP-
guinea pig albumin (GPA), display anormal delayed hypersensitivity response to
DNP-GPA . Furthermore, lymph node cells from those tolerized animals incorpo-
rate thymidine into DNA when stimulated with antigen in amounts equivalent
to cells from normal immune animals . Thus, cellular immune responses
(T-cell-mediated function) to DNP-GPA are normal in guinea pigs pretreated
with DNP-D-GL . Basically, the same result was also reported by Benacerraf and
Katz (33), in that treatment with DNP-D-GL, which suppresses anti-DNP
antibody responses in virgin and primed guinea pigs, does not affect the ability of
these animals to develop and to display contact sensitivity to DNCB . Moreover,
as will be reported from our laboratory using mice,' DNP-reactive helper T
lymphocytes generated by immunization with DNP-MGG failed to be tolerized
by treatment with DNP-D-GL . These observations confirm the suggestions that
important operational differences, such as a basic specificity distinction of
receptors, exist in the induction of tolerance in T and B lymphocytes presumed to
be concerned with the same DNP specificity .
However, as demonstrated clearly in the present studies, PAB-D-GL treatmentT. HAMAOKA, U . YAMASHITA, T. TAKAMI, AND M . KITAGAWA
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of PAB-reactive helper T lymphocytes induces a profound state of tolerance . The
exact reasons for these conflicting results concerning the tolerogenic activity of
hapten-D-GL conjugates to different specificities ofT lymphocytes are not clear
at present . With reference to these discrepancies, the following two possibilities
may be worthwhile considering : (a) Differences in net charge or hapten-epitome
density of tolerogen are crucial for the D-GL conjugate to be highly tolerogenic to
T lymphocytes, since the PAB-D-GL molecule used in the present studies was
somewhat more acidic in net charge than DNP-D -GL and PAB residues were
more highly conjugated on D-GL in mono- or bis-substituted forms. (b) Because
of some heterogeneity of hapten-reactive helper T lymphocytes with respect to
receptor affinity, the induction of tolerance of the hapten-reactiveT cells may be
both dose and affinity dependent . Under the experimental conditions used to
tolerize DNP-reactive helper T cells by DNP-D-GL, the affinity of the receptors
on DNP-reactive T cells may be too low to be effectively tolerized with
DNP-D-GL . In contrast, PAB-reactive helper T cells such as used in the present
studies consist of, on the average, relatively higher affinity populations. In fact,
in the model of tolerance induction of PAB-reactive helper T cells with
PAB-D-GL, PAB-reactive helper T cells obtained from mice which had been
immunized 4 wk previously were found to be rather difficult to render tolerant
with PAB-D-GL
,3 whereas primed cells obtained from mice immunized for a
relatively longer period of time were easily tolerized, such as demonstrated in the
present studies . Furthermore, as shown in data to be presented separately,' the
increase in susceptibility to tolerance of long-primed PAB-reactive helper T-cell
population upon treatment with PAB-D-GL was exactly correlated with the loss
of cross-reactivity of those helper cells to various other cross-reactive hapten
conjugates such as o-azobenzoate-MGG and m-azobenzoate-MGG. In addition,
those long-primed PAB-reactive helper T cells elicited their full reactivity to
the stimulation of smaller amounts of DNP-MGG-PAB when cooperative inter-
action was elicited with DNP-specific B cells at various doses of second antigen .
These preliminary results' strongly suggest that specificity restriction and bind-
ing affinity of the receptors of PAB-reactive helper T lymphocytes may be more
crucial for the induction of T-cell tolerance .
In any case, the precise nature of events at the cellular and subcellular levels
that result in specific unresponsiveness with PAB-D-GL on the level of PAB-reac-
tive helper T lymphocytes awaits further investigations . Nonetheless, it may
finally be worthwhile pointing out that the establishment of a tolerance model
exclusively operating on the T-cell levels, such as described here, may provide
certain advantages in studies designed to probe the mechanism of specific
inactivation processes ofT lymphocytes by tolerogen .
Summary
Treatment of a p-azobenzoate (PAB) derivative of a copolymer of D-glutamic
acid and D-lysine (D-GL) induced a profound state of unresponsiveness to
PAB-reactive helper T lymphocytes generated in PAB-mouse gamma globulin
(MGG)-primed mice . This unresponsiveness in T lymphocytes was specific for
PAB-reactive cells, since the bacterial a-amylase-, keyhole limpet hemocyanin-,1326
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or ovalbumin-primed helper T lymphocytes were not suppressed by PAB-D-GL
treatment . Taking advantage of the relative ease with which PAB-D-GL can
induce specific unresponsiveness to helper T lymphocytes in an animal previ-
ously primed with PAB-MGG, it was possible to approach certain questions
concerning the mechanisms of tolerance-induction and the fate of tolerant helper
T lymphocytes in the PAB-D-GL model by utilizing a classical adoptive cell
transfer system . Elimination of the possibility of carry-over of the tolerogen with
cells or of the generation of suppressor cells as the result ofPAB-D-GL treatment
as an explanation of the suppression of helper T-cell activity strongly inplicates
the existence of a central intracellular mechanism of specific tolerance on the
helper T-cell level . The possibility that suppression of the activity of PAB-reac-
tive helper T lymphocytes by PAB-D-GL reflects simple blocking of surface
receptor molecules on T lymphocytes was ruled out as it was found that the
helper activity of PAB-reactive cells was minimally suppressed even when
PAB-D-GL was directly exposed in vitro to helper T lymphocytes . Moreover, the
most conclusive evidence on this point derives from the ultimate failure of en-
zymatic treatment with trypsin to reverse the tolerant state induced by in vivo
exposure of primed T cells to PAB-D-GL . It appears, therefore, that specific
tolerance induced by PAB-D-GL to PAB-reactive helper T lymphocytes is an
example of irreversible inhibition of T-cell reactivity to antigen, reflecting yet to
be determined events at the intra- and subcellular levels .
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